Committees
The members of the Organizing Committee (OC) discuss on frequent basis the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
The members of Scientific Committee assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee actively participate in the review process of the submitted abstracts.
Francesca Aweeka
University of California, San Francisco, USA
Richard Bertz
Bristol-Myers Squibb, USA
Marta Boffito
St. Stephen’s Center London, United Kingdom
Rudolphe Garraffo
Hôpital Pasteur Nice, France
David Haas
Vanderbilt University School of Medicine, USA
Rick Haubrich
University of California San Diego, USA
Daria Hazuda
Merck, USA
Thomas Kakuda
Tibotec, USA
Brian Kearney
Gilead Sciences, USA
Anther Keung
Schering Plough, USA
Cheri Klein
Abbott, USA
Michael Kurowski
Auguste-Viktoria Hospital, Germany
Doug Mayers
Idenix Pharmaceuticals, USA
Gary Muirhead
Pfizer, United Kingdom
Gilles Peytavin
Bichat-Claude Bernard Hospital, France
Elizabeth Phillips
Royal Perth Hospital, Australia
Stephen Piscitelli
GlaxoSmithKline, USA
Charles La Porte
Ottawa Health Research Institute, Canada
Mario Regazzi
IRCCS-Policlinico S. Matteo, Italy
John Sabo
Boehringer-Ingelheim, USA
Kimberly Struble
Food & Drug Administration, USA
Steve Taylor
Heartland Hospital Birmingham, United Kingdom
Amalio Telenti
University Hospital Lausanne, Switzerland
Alice Tseng
Toronto General Hospital, Canada
Manoli Vourvahis, PharmD
Pfizer, USA
Carla Washington
Roche Pharmaceuticals, USA
